GSK256066

DESCRIPTION

GSK256066 is a selective and high-affinity phosphodiesterase 4 (PDE4) inhibitor, with an IC50 of 3.2 pM for PDE4B. GSK256066 is developed for the research of chronic obstructive pulmonary disease[1].

DETAILS

Purity: >98%
Smiles: O=C(N)C1=C(C2=CC(S(=O)(C3=CC=CC(C(N(C)C)=O)=C3)=O)=CC(C)=C2N=C1)NC4=CC=CC(OC)=C4
Category: Reference compound
Lead Time: 1-2 days
Cas Number: 801312-28-7
Molecular Weight: 518.58
Molecular Formula: C27H26N4O5S

Lead Time: 1-2 days